1887

Abstract

Human parvovirus B19 (B19) infection during pregnancy is associated with the adverse foetal outcome known as non-immune hydrops fetalis (NIHF). Although B19 is known to infect erythroid-lineage cells as well as , the mechanism leading to the occurrence of NIHF is not clear. To investigate the possible involvement of the B19 non-structural protein NS1 in NIHF, three independent lines of transgenic mice were generated that expressed NS1 under the control of the Cre- system and the GATA1 promoter. Two of the three lines expressed NS1 in erythroid-lineage cells. Most of the transgenic mice died at the embryonic stage, some of which developed hydropic changes caused by severe anaemia at embryonic day 15·5 (E15·5). Histological examination of embryos at E15·5 showed significantly fewer erythropoietic islands in the liver parenchyma, whereas their hearts showed no abnormal signs, such as cardiomegaly and apoptotic cells. The NS1-transgenic mouse lines established here provide an animal model for human NIHF and suggest that NS1 plays a crucial role in the adverse outcome associated with intrauterine B19 infection in humans.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-2-273
2002-02-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/2/0830273a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-2-273&mimeType=html&fmt=ahah

References

  1. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L., Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet i, 1378
    [Google Scholar]
  2. Barbany G., Hagberg A., Olsson-Strömberg U., Simonsson B., Syvänen A. C., Landegren U. 2000; Manifold-assisted reverse transcription–PCR with real-time detection for measurement of the BCR-ABL fusion transcript in chronic myeloid leukemia patients. Clinical Chemistry 46:913–920
    [Google Scholar]
  3. Bièche I., Onody P., Laurendeau I., Olivi M., Vidaud D., Lidereau R., Vidaud M. 1999; Real-time reverse transcription–PCR assay for future management of ERBB2-based clinical applications. Clinical Chemistry 45:1148–1156
    [Google Scholar]
  4. Brown K. E., Young N. S. 1997; Parvovirus B19 in human disease. Annual Review of Medicine 48:59–67
    [Google Scholar]
  5. Brown T., Anand A., Ritchie L. D., Clewley J. P., Reid T. M. 1984; Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii:1033–1034
    [Google Scholar]
  6. Brown K. E., Anderson S. M., Young N. S. 1993; Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117
    [Google Scholar]
  7. Brown K. E., Hibbs J. R., Gallinella G., Anderson S. M., Lehman E. D., McCarthy P., Young N. S. 1994; Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). New England Journal of Medicine 330:1192–1196
    [Google Scholar]
  8. Cossart Y. E., Field A. M., Cant B., Widdows D. 1975; Parvovirus-like particles in human sera. Lancet i:72–73
    [Google Scholar]
  9. Doerig C., Hirt B., Antonietti J. P., Beard P. 1990; Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. Journal of Virology 64:387–396
    [Google Scholar]
  10. Fujiwara Y., Browne C. P., Cunniff K., Goff S. C., Orkin S. H. 1996; Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proceedings of the National Academy of Sciences, USA 93:12355–12358
    [Google Scholar]
  11. Kelleher J. F., Luban N. L., Mortimer P. P., Kamimura T. 1983; Human serum ‘parvovirus’: a specific cause of aplastic crisis in children with hereditary spherocytosis. Journal of Pediatrics 102:720–722
    [Google Scholar]
  12. Lakso M., Sauer B., Mosinger B. Jr, Lee E. J., Manning R. W., Yu S.-H., Mulder K. L., Westphal H. 1992; Targeted oncogene activation by site-specific recombination in transgenic mice. Proceedings of the National Academy of Sciences, USA 89:6232–6236
    [Google Scholar]
  13. Lambot M.-A., Noël J.-C., Peny M.-O., Rodesch F., Haot J. 1999; Fetal parvovirus B19 infection associated with myocardial necrosis. Prenatal Diagnosis 19:389
    [Google Scholar]
  14. Levy R., Weissman A., Blomberg G., Hagay Z. J. 1997; Infection by parvovirus B19 during pregnancy: a review. Obstetrical and Gynecological Survey 52:254–259
    [Google Scholar]
  15. Miller E., Fairley C. K., Cohen B. J., Seng C. 1998; Immediate and long term outcome of human parvovirus B19 infection in pregnancy. British Journal of Obstetrics and Gynaecology 105:174–178
    [Google Scholar]
  16. Moffatt S., Tanaka N., Tada K., Nose M., Nakamura M., Muraoka O., Hirano T., Sugamura K. 1996; A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. Journal of Virology 70:8485–8491
    [Google Scholar]
  17. Moffatt S., Yaegashi N., Tada K., Tanaka N., Sugamura K. 1998; Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. Journal of Virology 72:3018–3028
    [Google Scholar]
  18. Momoeda M., Wong S., Kawase M., Young N. S., Kajigaya S. 1994; A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. Journal of Virology 68:8443–8446
    [Google Scholar]
  19. Morey A. L., Keeling J. W., Porter H. J., Fleming K. A. 1992; Clinical and histopathological features of parvovirus B19 infection in human fetus. British Journal of Obstetrics and Gynaecology 99:566–574
    [Google Scholar]
  20. Morey A. L., Ferguson D. J., Fleming K. A. 1993; Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis. Journal of Pathology 169:213–220
    [Google Scholar]
  21. Morita E., Tada K., Chisaka H., Asao H., Sato H., Yaegashi N., Sugamura K. 2001; Human parvovirus B19 induces cell cycle arrest at G2 phase with accumulation of mitotic cyclins. Journal of Virology 75:7555–7563
    [Google Scholar]
  22. Mucenski M. L., McLain K., Kier A. B., Swerdlow S. H., Schreiner C. M., Miller T. A., Pietryga D. W., Scott W. J. Jr, Potter S. S. 1991; A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677–689
    [Google Scholar]
  23. Naides S. J., Weiner C. P. 1989; Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenatal Diagnosis 9:105–114
    [Google Scholar]
  24. Onodera K., Takahashi S., Nishimura S., Ohta J., Motohashi H., Yomogida K., Hayashi N., Engel J. D., Yamamoto M. 1997; GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proceedings of the National Academy of Sciences, USA 94:4487–4492
    [Google Scholar]
  25. Orban P. C., Chui D., Marth J. D. 1992; Tissue- and site-specific DNA recombination in transgenic mice. Proceedings of the National Academy of Sciences, USA 89:6861–6865
    [Google Scholar]
  26. Ozawa K., Kurtzman G., Young N. S. 1986; Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233:883–886
    [Google Scholar]
  27. Ozawa K., Ayub J., Hao Y.-S., Kurtzman G., Shimada T., Young N. S. 1987; Novel transcription map for the B19 (human) pathogenic parvovirus. Journal of Virology 61:2395–2406
    [Google Scholar]
  28. Ozawa K., Ayub J., Kajigaya S., Shimada T., Young N. S. 1988; The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. Journal of Virology 62:2884–2889
    [Google Scholar]
  29. Pevny L., Simon M. C., Robertson E., Klein W. H., Tsai S. F., D’Agati V., Orkin S. H., Constantini F. 1991; Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257–260
    [Google Scholar]
  30. Porter H. J., Quantrill A. M., Fleming K. A. 1988; B19 parvovirus infection of myocardial cells. Lancet i:535–536
    [Google Scholar]
  31. Rouger P., Gane P., Salmon C. 1987; Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies. Revue Française de Transfusion et d’Immunohematologie 30:699–708
    [Google Scholar]
  32. Sakai K., Miyazaki J. 1997; A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochemical and Biophysical Research Communications 237:318–324
    [Google Scholar]
  33. Shimomura S., Komatsu N., Frickhofen N., Anderson S., Kajigaya S., Young N. S. 1992; First continuous propagation of B19 parvovirus in a cell line. Blood 79:18–24
    [Google Scholar]
  34. Shivdasani R. A., Orkin S. H. 1996; The transcriptional control of hematopoiesis. Blood 87:4025–4039
    [Google Scholar]
  35. Socolovsky M., Fallon A. E. J., Wang S., Brugnara C., Lodish H. F. 1999; Fetal anemia and apoptosis of red cell progenitors in Stat5a−/−5b−/− mice: a direct role for Stat5 in Bcl-XL induction. Cell 98:181–191
    [Google Scholar]
  36. Sol N., Morinet F., Alizon M., Hazan U. 1993; Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product. Journal of General Virology 74:2011–2014
    [Google Scholar]
  37. Sol N., Le Junter J., Vassias I., Freyssinier J. M., Thomas A., Prigent A. F., Rudkin B. B., Fichelson S., Morinet F. 1999; Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. Journal of Virology 73:8762–8770
    [Google Scholar]
  38. Tolfvenstam T., Papadogiannakis N., Norbeck O., Petersson K., Broliden K. 2001; Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 357:1494–1497
    [Google Scholar]
  39. Yaegashi N., Shiraishi H., Takeshita T., Nakamura M., Yajima A., Sugamura K. 1989; Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. Journal of Virology 63:2422–2426
    [Google Scholar]
  40. Yaegashi N., Okamura K., Yajima A., Murai C., Sugamura K. 1994; The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis. Journal of Perinatal Medicine 22:159–163
    [Google Scholar]
  41. Yaegashi N., Niinuma T., Chisaka H., Watanabe T., Uehara S., Okamura K., Moffatt S., Sugamura K., Yajima A. 1998; The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. Journal of Infection 37:28–35
    [Google Scholar]
  42. Yaegashi N., Niinuma T., Chisaka H., Uehara S., Moffatt S., Tada K., Iwabuchi M., Matsunaga Y., Nakayama M., Yutani C., Osamura Y., Hirayama E., Okamura K., Sugamura K., Yajima A. 1999; Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo. Journal of Infection 39:68–76
    [Google Scholar]
  43. Young N. 1988; Hematologic and hematopoietic consequences of B19 parvovirus infection. Seminars in Hematology 25:159–172
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-2-273
Loading
/content/journal/jgv/10.1099/0022-1317-83-2-273
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error